Explore 3 Stock Ideas & Industry Insights Download Free Report

blue-chip

One NYSE- Listed Insurance Stock to Consider in Current Increased Volatility Environment– Ryan Specialty Holdings Inc

Mar 05, 2025 | Team Kalkine
One NYSE- Listed Insurance Stock to Consider in Current Increased Volatility Environment– Ryan Specialty Holdings Inc
Image source: shutterstock

  • RYAN:NYSE
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Ryan Specialty Holdings Inc

Ryan Specialty Holdings, Inc. (NYSE: RYAN) is a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It provides distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter with delegated authority from insurance carriers.

Recent Business and Financial Updates

  • Financial Performance Overview: Ryan Specialty Holdings, Inc. (NYSE: RYAN), a prominent international specialty insurance firm, reported robust financial results for the fourth quarter and full year 2024. The Company achieved a 24.5% year-over-year increase in total revenue, reaching USD 663.5 million for the fourth quarter. This growth was primarily driven by an Organic Revenue Growth Rate of 11.0%, bolstered by new client acquisitions, expanded client relationships, and contributions from recent acquisitions. Adjusted EBITDAC rose 36.2% to USD 216.0 million, reflecting operational efficiency and sustained business expansion. However, net income for the quarter declined by 27.3% to USD 42.6 million due to higher income tax and interest expenses, partially offset by strong revenue growth. Adjusted net income increased 28.9% to USD 123.3 million, while Adjusted EBITDAC Margin improved to 32.6%, up from 29.8% in the prior-year period.
  • Annual Performance and Revenue Growth: For the full year 2024, total revenue rose 21.1% year-over-year to USD 2,515.7 million, supported by an Organic Revenue Growth Rate of 12.8%. Net income increased by 18.2% to USD 229.9 million, driven by consistent business expansion and strategic acquisitions. Adjusted EBITDAC surged by 29.8% to USD 811.2 million, while Adjusted Net Income grew by 31.4% to USD 493.5 million. The Company distributed USD 102.4 million in dividends and distributions, including USD 27.1 million in special dividends.
  • Strategic Acquisitions and Market Expansion: Ryan Specialty Holdings remains focused on sustainable growth through strategic mergers and acquisitions. In 2024, the Company completed seven acquisitions, contributing over USD 265 million in annualized revenue. The Company began 2025 by finalizing the acquisition of Velocity Risk Underwriters, aligning specialized underwriting products with its distribution expertise. This strategy aims to enhance market share, expand capabilities, and offer diversified solutions to clients.
  • Liquidity and Capital Management: As of December 31, 2024, Ryan Specialty Holdings reported USD 540.2 million in cash and cash equivalents, alongside USD 3.3 billion in outstanding debt principal. The Board of Directors declared an increased quarterly dividend of USD 0.12 per share, payable on March 18, 2025. These capital management measures reflect the Company's commitment to returning value to shareholders while maintaining financial stability.
  • Operational Efficiency and Profitability: The increase in Adjusted EBITDAC Margin to 32.6% in the fourth quarter of 2024 highlights the Company’s operational efficiency. Cost containment initiatives, coupled with revenue growth, have contributed to the improvement in profitability. The Company remains dedicated to sustaining its competitive cost structure and enhancing shareholder value.
  • Outlook for 2025: Looking ahead, Ryan Specialty Holdings anticipates an Organic Revenue Growth Rate between 11.0% and 13.0% and an Adjusted EBITDAC Margin between 32.5% and 33.5% for the full year 2025. The Company’s strategic acquisitions, operational efficiency, and strong liquidity position are expected to support continued value creation and long-term growth.

Technical Observation (on the daily chart):

The Relative Strength Index (RSI) over a 14-day period stands at a value of 58.86, upward trending and moving towards overbought zone, with expectations of a consolidation or an upward momentum if the important support levels of USD65- USD 70 hold. Additionally, the stock's current positioning is above both 50-Day SMA and 200-Day SMA, which can act as a short to medium term support levels.

Ryan Specialty Holdings, Inc. (NYSE: RYAN) reported exceptional financial results for 2024, underscoring its robust business model and strategic focus, with fourth-quarter total revenue increasing 24.5% year-over-year to USD 663.5 million and full-year revenue rising 21.1% to USD 2,515.7 million, driven by a 12.8% Organic Revenue Growth Rate and contributions from seven strategic acquisitions adding over USD 265 million in annualized revenue. Adjusted EBITDAC grew significantly by 36.2% to USD 216.0 million in Q4 and 29.8% to USD 811.2 million for the year, with an improved Adjusted EBITDAC Margin of 32.6%, despite a 27.3% decline in Q4 net income to USD 42.6 million due to higher taxes and interest expenses, though Adjusted Net Income rose 28.9% to USD 123.3 million, reflecting operational efficiency and cost discipline. The Company maintained strong liquidity with USD 540.2 million in cash and cash equivalents as of December 31, 2024, increased its quarterly dividend to USD 0.12 per share, and completed the acquisition of Velocity Risk Underwriters in early 2025 to enhance its underwriting and distribution capabilities, positioning it for sustained growth with projected 2025 Organic Revenue Growth of 11.0%–13.0% and an Adjusted EBITDA Margin of 32.5%–33.5%, ensuring long-term value creation. 

As per the above-mentioned price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis, a ‘Buy’ rating has been given to Ryan Specialty Holdings, Inc. (NYSE: RYAN) at the closing price of USD 69.98, as of March 04, 2025. 

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is March 04, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.